Search Results

There are 4553 results for: content related to: Limitations with the response evaluation criteria in solid tumors (RECIST) guidance in disseminated pediatric malignancy

  1. You have free access to this content
    Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 147–156, Julien Edeline, Eveline Boucher, Yan Rolland, Elodie Vauléon, Marc Pracht, Christophe Perrin, Catherine Le Roux and Jean-Luc Raoul

    Version of Record online : 28 JUN 2011, DOI: 10.1002/cncr.26255

  2. You have free access to this content
    Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy

    Cancer

    Volume 118, Issue 23, 1 December 2012, Pages: 5857–5866, Silvia Stacchiotti, Paolo Verderio, Antonella Messina, Carlo Morosi, Paola Collini, Antonio Llombart-Bosch, Javier Martin, Alessandro Comandone, Jurado Cruz, Andrea Ferraro, Giovanni Grignani, Sara Pizzamiglio, Vittorio Quagliuolo, Piero Picci, Sergio Frustaci, Angelo Paolo Dei Tos, Paolo G. Casali and Alessandro Gronchi

    Version of Record online : 17 MAY 2012, DOI: 10.1002/cncr.27624

  3. Radiologic response to transcatheter hepatic arterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma

    Liver International

    Volume 34, Issue 2, February 2014, Pages: 305–312, Chang Joon Kim, Hong Joo Kim, Jung Ho Park, Dong Il Park, Yong Kyun Cho, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim and Min-Ji Kim

    Version of Record online : 25 JUL 2013, DOI: 10.1111/liv.12270

  4. You have free access to this content
    Response assessment in gastrointestinal stromal tumor

    International Journal of Cancer

    Volume 128, Issue 6, 15 March 2011, Pages: 1251–1258, Jayesh Desai

    Version of Record online : 7 JAN 2011, DOI: 10.1002/ijc.25729

  5. Comparison of tumor response assessment methods in patients with metastatic colorectal cancer after locoregional therapy

    Journal of Surgical Oncology

    Volume 113, Issue 4, March 15, 2016, Pages: 443–448, Olaguoke Akinwande, Prejesh Philips, Charles R. Scoggins, Lawrence Kelly, Cliff Tatum, Mike Hahl, Kelly M. McMasters and Robert C.G. Martin

    Version of Record online : 6 APR 2016, DOI: 10.1002/jso.24141

  6. You have full text access to this OnlineOpen article
    Significance of different response evaluation criteria in predicting progression-free survival of lung cancer with certain imaging characteristics

    Thoracic Cancer

    Dengxia Yang, Gavitt Woodard, Chan Zhou, Xinyue Wang, Zhujun Liu, Zhaoxiang Ye and Kai Li

    Version of Record online : 21 JUN 2016, DOI: 10.1111/1759-7714.12363

  7. Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinoma

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1111–1121, Adeel R. Seyal, Fernanda D. Gonzalez-Guindalini, Atilla Arslanoglu, Carla B. Harmath, Robert J. Lewandowski, Riad Salem and Vahid Yaghmai

    Version of Record online : 19 JUN 2015, DOI: 10.1002/hep.27915

  8. You have free access to this content
    Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma

    Cancer

    Volume 115, Issue 3, 1 February 2009, Pages: 616–623, Alejandro Forner, Carmen Ayuso, María Varela, Jordi Rimola, Amelia J. Hessheimer, Carlos Rodriguez de Lope, María Reig, Luís Bianchi, Josep M. Llovet and Jordi Bruix

    Version of Record online : 30 DEC 2008, DOI: 10.1002/cncr.24050

  9. You have free access to this content
    Response Assessment in Paediatric Phase I Trials According to RECIST Guidelines: Survival Outcomes, Patterns of Progression and Relevance of Changes in Tumour Measurements

    Pediatric Blood & Cancer

    Volume 63, Issue 8, August 2016, Pages: 1400–1406, Fernando Carceller, Francisco J. Bautista, Lucy A. Fowkes, Lynley V. Marshall, Sara I. Sirvent, Julia C. Chisholm, Andrew D.J. Pearson, Dow-Mu Koh and Lucas Moreno

    Version of Record online : 3 MAY 2016, DOI: 10.1002/pbc.26039

  10. Clinicopathologic features associated with efficacy and long-term survival in metastatic melanoma patients treated with BRAF or combined BRAF and MEK inhibitors

    Cancer

    Volume 121, Issue 21, November 1, 2015, Pages: 3826–3835, Alexander M. Menzies, James S. Wilmott, Martin Drummond, Serigne Lo, Megan Lyle, Matthew M. K. Chan, John F. Thompson, Alex Guminski, Matteo S. Carlino, Richard A. Scolyer, Richard F. Kefford and Georgina V. Long

    Version of Record online : 28 JUL 2015, DOI: 10.1002/cncr.29586

  11. You have full text access to this Open Access content
    Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients

    Cancer Science

    Volume 97, Issue 3, March 2006, Pages: 214–218, Hirokazu Watanabe, Hideo Kunitoh, Seiichiro Yamamoto, Shin Kawasaki, Akira Inoue, Katsuyuki Hotta, Kazu Shiomi, Masahiko Kusumoto, Kazuro Sugimura and Nagahiro Saijo

    Version of Record online : 14 FEB 2006, DOI: 10.1111/j.1349-7006.2006.00157.x

  12. Imaging as a Localized Biomarker: Opportunities and Challenges

    Standard Article

    Pharmaceutical Sciences Encyclopedia

    Jonathan B. Moody, Philip S. Murphy and Edward P. Ficaro

    Published Online : 15 MAR 2010, DOI: 10.1002/9780470571224.pse255

  13. You have full text access to this Open Access content
    Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial

    Cancer Science

    Volume 104, Issue 6, June 2013, Pages: 718–724, Clemens Giessen, Ruediger P. Laubender, Ludwig Fischer von Weikersthal, Andreas Schalhorn, Dominik P. Modest, Sebastian Stintzing, Michael Haas, Ulrich R. Mansmann and Volker Heinemann

    Version of Record online : 14 APR 2013, DOI: 10.1111/cas.12148

  14. You have free access to this content
    Clinical outcomes of systemic therapy for patients with deep fibromatosis (desmoid tumor)

    Cancer

    Volume 116, Issue 9, 1 May 2010, Pages: 2258–2265, Veridiana Pires de Camargo, Mary L. Keohan, David R. D'Adamo, Cristina R. Antonescu, Murray F. Brennan, Samuel Singer, Linda S. Ahn and Robert G. Maki

    Version of Record online : 24 FEB 2010, DOI: 10.1002/cncr.25089

  15. Hepatocellular carcinoma treated with sorafenib: early detection of treatment response and major adverse events by contrast-enhanced US

    Liver International

    Volume 33, Issue 4, April 2013, Pages: 605–615, Katsutoshi Sugimoto, Fuminori Moriyasu, Kazuhiro Saito, Nicolas Rognin, Naohisa Kamiyama, Yoshihiro Furuichi and Yasuharu Imai

    Version of Record online : 11 JAN 2013, DOI: 10.1111/liv.12098

  16. You have free access to this content
    The nature and management of metastatic melanoma after progression on BRAF inhibitors: Effects of extended BRAF inhibition

    Cancer

    Volume 120, Issue 20, October 15, 2014, Pages: 3142–3153, Matthew M. K. Chan, Lauren E. Haydu, Alexander M. Menzies, Mary W. F. Azer, Oliver Klein, Megan Lyle, Arthur Clements, Alexander Guminski, Richard F. Kefford and Georgina V. Long

    Version of Record online : 1 JUL 2014, DOI: 10.1002/cncr.28851

  17. Tumor histopathology predicts outcomes after resection of colorectal cancer liver metastases treated with and without pre-operative chemotherapy

    Journal of Surgical Oncology

    Volume 113, Issue 4, March 15, 2016, Pages: 456–462, Srinevas K. Reddy, Robin J. Parker, Joseph W. Leach, Mark J. Hill and Lawrence J. Burgart

    Version of Record online : 12 JAN 2016, DOI: 10.1002/jso.24144

  18. You have free access to this content
    Radiological-pathological analysis of WHO, RECIST, EASL, mRECIST and DWI: Imaging analysis from a prospective randomized trial of Y90 ± sorafenib

    Hepatology

    Volume 58, Issue 5, November 2013, Pages: 1655–1666, Michael Vouche, Laura Kulik, Rohi Atassi, Khairuddin Memon, Ryan Hickey, Daniel Ganger, Frank H. Miller, Vahid Yaghmai, Michael Abecassis, Talia Baker, Mary Mulcahy, Ritu Nayar, Robert J. Lewandowski and Riad Salem

    Version of Record online : 1 OCT 2013, DOI: 10.1002/hep.26487

  19. You have free access to this content
    A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma

    Cancer

    Volume 121, Issue 10, May 15, 2015, Pages: 1620–1627, Mairéad G. McNamara, Lisa W. Le, Anne M. Horgan, Alex Aspinall, Kelly W. Burak, Neesha Dhani, Eric Chen, Mehrdad Sinaei, Glen Lo, Tae Kyoung Kim, Patrik Rogalla, Oliver F. Bathe and Jennifer J. Knox

    Version of Record online : 6 JAN 2015, DOI: 10.1002/cncr.29227

  20. You have free access to this content
    Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer

    Intervention Review

    The Cochrane Library

    Alison J Wiggans, Gemma KS Cass, Andrew Bryant, Theresa A Lawrie and Jo Morrison

    Published Online : 20 MAY 2015, DOI: 10.1002/14651858.CD007929.pub3